Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-42,300
Closed -$2.44M 3651
2024
Q3
$2.44M Buy
42,300
+11,700
+38% +$632K 0.01% 1430
2024
Q2
$1.48M Sell
30,600
-4,200
-12% -$203K ﹤0.01% 1734
2024
Q1
$1.69M Buy
34,800
+28,700
+470% +$1.4M ﹤0.01% 1582
2023
Q4
$303K Buy
+6,100
New +$298K ﹤0.01% 3194

Other funds holding SNY

GTS Securities's SNY Position: Q2 2025 in Review

GTS Securities sold out of Sanofi (SNY) in Q2 2025, closing a stake of 16,219 shares — an estimated $900K sold.

GTS Securities first reported a position in SNY in Q2 2023 and held it in 7 quarters. The position peaked at $5.99M in Q3 2024. 730 funds tracked by Wall St. Rank hold SNY as of Q2 2025.

  • GTS Securities reported no remaining Sanofi position as of Q2 2025 after selling out during the quarter.
  • GTS Securities sold 16,219 Sanofi shares in Q2 2025, an estimated $900K.
  • GTS Securities first reported a position in Sanofi in Q2 2023 and held it in 7 quarters.
  • GTS Securities's Sanofi position peaked at $5.99M in Q3 2024.
  • 730 funds tracked by Wall St. Rank held Sanofi as of Q2 2025.

Based on GTS Securities's 13F filing for Q2 2025, filed 8 Aug 2025.